Director, Real World Late-Phase Strategy & Delivery

Syneos Health, Inc.

United Kingdom

Presencial

GBP 120.000 - 180.000

Jornada completa

Hace 7 días
Sé de los primeros/as/es en solicitar esta vacante

Consigue una respuesta de este empleador

Tu currículum y tu carta de presentación, adaptados exactamente a lo que buscan contratar.

Supera los filtros ATS

Descripción de la vacante

The Director, Strategy & Delivery, Real World Late Phase (RWLP), independently leads customer engagements from pre-award strategy through study delivery at Syneos Health. The role combines ownership of study strategy, proposal development and bid defenses with operational and financial oversight of assigned studies, programs and portfolios.

The Director partners with Business Development, Medical Strategy, Epidemiology and Biostatistics to translate evidence needs into feasible study plans,

Formación

  • Director level role focusing on RWLP strategy and delivery.
  • Experience in leading multi-disciplinary teams and client engagements.

Responsabilidades

  • Lead RWLP strategy for opportunities, aligning evidence needs with study design, feasibility and budget.
  • Lead proposal development, bid defenses and transition to delivery with clear ownership of commitments.
  • Partner with Business Development and account leaders to develop relationships and grow opportunities.

Descripción del empleo

The Director, Strategy & Delivery, Real World Late Phase (RWLP), independently leads customer engagements from pre-award strategy through study delivery at Syneos Health. The role combines ownership of study strategy, proposal development and bid defenses with operational and financial oversight of assigned studies, programs and portfolios.

The Director partners with Business Development, Medical Strategy, Epidemiology and Biostatistics to translate evidence needs into feasible study plans,

Consigue la evaluación confidencial y gratuita de tu currículum.

o arrastra y suelta tu archivo aquí

Similar jobs

Puestos de trabajo similares que vale la pena comparar

Director Strategy and Delivery Real World Late Phase
Director Strategy and Delivery Real World Late Phase

Syneos Health • Gran Bretaña

Presencial
GBP 120.000 - 180.000
Director, Real-World & Late-Phase Clinical Operations
Director, Real-World & Late-Phase Clinical Operations

Pharma Search • England

Presencial
GBP 80.000 - 130.000
Director, Clinical Operations Real-World and Late Phase Research
Director, Clinical Operations Real-World and Late Phase Research

Pharma Search • England

Presencial
GBP 80.000 - 130.000
Director of Real World Evidence & Epidemiology
Director of Real World Evidence & Epidemiology

Genesis Research Group • Gran Bretaña

Presencial
GBP 120.000 - 170.000
Performance-related bonus
Generous time off entitlement
Equal opportunity employer
Director, Scientific Sales & Delivery — RWE
Director, Scientific Sales & Delivery — RWE

PHARMO Institute, part of Lumanity • Greater London

Híbrido
GBP 90.000 - 130.000
Competitive salary
Attractive pension scheme
Flexible working hours
+1
Director, Scientific Sales & Delivery – RWE Leader
Director, Scientific Sales & Delivery – RWE Leader

Lumanity • Greater London

Híbrido
GBP 90.000 - 140.000
Competitive salary
Flexible working hours
Hybrid working
+2
Director of Global Regulatory Pre‑Award Strategy
Director of Global Regulatory Pre‑Award Strategy

Worldwide Clinical Trials • England

Presencial
GBP 80.000 - 120.000
Global Director, Regulatory Pre-Award Strategy (Remote)
Global Director, Regulatory Pre-Award Strategy (Remote)

worldwide.com • Gran Bretaña

A distancia
GBP 80.000 - 100.000
Inclusive work environment
Opportunity for professional development
Flexible working conditions
Director of Business Development – Real-World Evidence Growth
Director of Business Development – Real-World Evidence Growth

ICON Clinical Research • Reading

Presencial
GBP 110.000 - 150.000
Annual leave
Health insurance
Retirement planning
+3
Senior Real-World Statistics Lead
Senior Real-World Statistics Lead

Vertex Inc. • City of Westminster

Híbrido
GBP 110.000 - 170.000